Ranolazine (C20f8d18 1ed7 4f03 9df2 B0fbf38bb35c 01)
Ranolazine Tablet, Film Coated, Extended Release
Product Images NDC 68180-355
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 68180-355). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Ndc 68180-354-07ranolazine Extended-release Tablets 500 mgrx Only Container Label: Bottle Of 60 Tablets (C20f8d18 1ed7 4f03 9df2 B0fbf38bb35c 02)
Ranolazine is a medication that comes in the form of extended-release tablets, contained in a bottle of 60 tablets. Each tablet is coated with a film and contains 500 mg of the medication, Ranolazine. It is important to swallow the tablets whole and not crush, break, or chew them. The complete dosing instructions are in the accompanying prescribing information. The tablets should be stored around 25°C (77°F), with excursions permitted to 15° to 30°C (58°to 86°F) as per USP Controlled Room Temperature. The product is manufactured by Lupin Limited, Goa, India, for Lupin Pharmaceuticals, Inc. located in Baltimore, Maryland, 21202, United States.*
Ndc 68180-355-07ranolazine Extended-release Tablets 1000 mgrx Only Container Label: Bottle Of 60 Tablets (C20f8d18 1ed7 4f03 9df2 B0fbf38bb35c 03)
This is a description of a prescription medication manufactured for Lupin Pharmaceuticals, Inc., containing 1000 mg of ranolazine per film-coated extended-release tablet. The dosage and use instructions are provided in accompanying prescribing information. The tablets should be swallowed whole and should not be crushed, broken, or chewed. The medication should be stored at 25°C (77°F) with permitted excursions between 15° to 30°C (59° to 86°F) and should be kept in USP Controlled Room Temperature. The tablet's manufacture is also provided, which is Lupin Limited, located in Goa, 403 722 INDIA. The code number is GO/DRUGS/654, and 60 tablets are included in the prescription.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
